Call for abstracts

Foreign presenters and Co-speakers do not have to be members of the Japanese Association for Thoracic Surgery (JATS)

*For those who are interested in becoming JATS members, please contact the Japanese Association for Thoracic Surgery:
1F Teral Koraku Building, 2-3-27 Koraku, Bunkyo-ku, Tokyo 112-0004, JAPAN
Phone: +81-3-3812-4253　Fax: +81-3-3816-4560
URL: http://www.jpats.org/　E-mail: jats-adm@umin.ac.jp

1．Presentations must be of original material and being presented for the first time.

2．Once presentations are approved by the Program Committee, Copyright of the presentations will be assumed by the Japanese Association for Thoracic Surgery.

3．Application procedure

1- Application period

Opens at noon on February 15, 2023 (JST/GMT+9)
Closes at noon on April 19, 2023 (JST/GMT+9)

2- Submissions

1. Recommended Browsers

To use the online abstract submission system, please use the latest version of Firefox, Google Chrome, Microsoft Edge or Safari.

*Internet Explorer (IE) or any other browsers are non-compliant browsers for the online abstract submission system.

2. Abstract Submission Number and Password

During the course of entering your information, you will be required to set your own password.
Upon completion of the abstract submission process, you will be given your abstract submission number. Your abstract submission number and password are very important, so please keep them safe and confidential.
We, the Program Secretariat, will use the abstract submission number when contacting you.
Please note, we will not respond to inquiries regarding security issues. Your abstract submission number and password may be used to login and modify your abstract and information up until the submission deadline (at noon on April 19, 2023, JST/GMT+9).

3. Abstract Specifications

Language: English
Abstract Title: Limited to 200 characters
Abstract Text: Limited to 2,000 characters
Figures and Tables: A single GIF or JPEG file no larger than 300KB

(portrait or landscape accepted; size will be reduced to approximately 6*4 cm).

4. Confirmation of Submission

After submitting your abstract, you will receive a confirmation e-mail. You may use the submission link to view and modify your abstract at any time up until the abstract submission deadline.
If you do not receive confirmation by e-mail, please contact the Program Secretariat:
jats2023-prog@congre.co.jp

5. Notification of Acceptance

The Program committee will carefully review all submitted abstracts, consider the reviews, and then make a final decision on which papers to select.
The first author will receive a notification of acceptance via email by the end of July.
The paper selection results will also be listed on the congress website.
Following the notification of acceptance, the first author must register for the 76th Annual Meeting, and abstracts can only be presented upon receipt of the registration fee.

6. Video Submission

For those presenting in Video Symposiums, Video Workshops, Video Clinics, and Clinical Video Sessions, please place a check mark “✔” under the “video” when submitting your abstract.
Once completing the abstract submission process, please return to the “Call for Abstracts” page to upload your video for review. Click on the “Upload Video” button to the appropriate session type to complete the video upload process. In this process, you are required to enter your “Abstract submission number”, so please retain your number.

●Primary Session

E. Esophagus
06_Video Symposium
Feasibility and safety of minimally invasive approach for locally advanced cT3br or cT4 esophageal cancer

●Oral/Poster Presentation, Clinical Video Session

• T. Cross-disciplinary

01	T-1	Cross-disciplinary/Combined cardiothoracic surgery (heart/aorta+α)
02	T-2	Cross-disciplinary/Combined cardiothoracic surgery (lung+α)
03	T-3	Cross-disciplinary/Combined cardiothoracic surgery (esophagus+α)

• H. Heart

04	H-1	Heart/Valvular disease-aortic
05	H-2	Heart/Valvular disease-mitral
06	H-3	Heart/Valvular disease-tricuspid
07	H-4	Heart/Valvular disease-pulmonary
08	H-5	Heart/Valvular disease-combined
09	H-6	Heart/Valvular disease-MICS/Robotics
10	H-7	Heart/Valvular disease-TAVI/MitraClip
11	H-8	Heart/Valvular disease-infective endocarditis
12	H-9	Heart/Valvular disease-others
13	H-10	Heart/Ischemic heart disease-CABG
14	H-11	Heart/Ischemic heart disease-minimally invasive CABG
15	H-12	Heart/Ischemic heart disease-complications of myocardial infarction
16	H-13	Heart/Ischemic heart disease-others
17	H-14	Heart/Aorta-type A dissection
18	H-15	Heart/Aorta-type B dissection
19	H-16	Heart/Aorta-complications of aortic dissection
20	H-17	Heart/Aorta-aortic root
21	H-18	Heart/Aorta-ascending/arch
22	H-19	Heart/Aorta-descending
23	H-20	Heart/Aorta-thoracoabdominal
24	H-21	Heart/Aorta-esophageal/bronchial fistula
25	H-22	Heart/Aorta-infected aneurysm/graft infection
26	H-23	Heart/Aorta-others
27	H-24	Heart/Combined surgery (valve, coronary, aorta, etc.)
28	H-25	Heart/Arrhythmia/pacemaker
29	H-26	Heart/Maze surgery
30	H-27	Heart/Closure/resection of LAA
31	H-28	Heart/Acyanotic congenital heart disease
32	H-29	Heart/Aortic arch anomaly/coarctation of aorta
33	H-30	Heart/Hypoplastic left heart syndrome: HLHS
34	H-31	Heart/Transposition of great arteries
35	H-32	Heart/Miscellaneous cyanotic diseases
36	H-33	Heart/Long-term issues/complications
37	H-34	Heart/Adult congenital heart disease
38	H-35	Heart/Cardiac tumor
39	H-36	Heart/Cardiomyopathy/myocarditis
40	H-37	Heart/Heart・heart-lung transplantation
41	H-38	Heart/Myocardial protection and metabolism
42	H-39	Heart/Extracorporeal circulation
43	H-40	Heart/Mechanical circulatory support/ventricular assisted system
44	H-41	Heart/Pulmonary circulation(CTEPH)
45	H-42	Heart/Perioperative management and complications
46	H-43	Heart/Examination and diagnosis
47	H-44	Heart/Experiment
48	H-45	Heart/New surgical techniques
49	H-46	Heart/Development and innovation
50	H-47	Heart/Regenerative medicine and tissue engineering
51	H-48	Heart/Others

• L. Lung

52	L-1	Lung/Lung cancer
53	L-2	Lung/Pulmonary metastasis
54	L-3	Lung/Mediastinum (thymic disease)
55	L-4	Lung/Mediastinum (non-thymic disease)
56	L-5	Lung/Pleura, chest wall, and thorax
57	L-6	Lung/Trachea and bronchus
58	L-7	Lung/Pneumothorax and emphysematous/bullous lung disease
59	L-8	Lung/Inflammatory lung diseases
60	L-9	Lung/Benign lung tumor
61	L-10	Lung/Pediatric lung disease
62	L-11	Lung/Minimally invasive surgery (Video-assisted and Robot-assisted thoracic surgery, VATS and RATS)
63	L-12	Lung/Salvage surgery
64	L-13	Lung/Lung transplantation and assisted circulation
65	L-14	Lung/New surgical techniques
66	L-15	Lung/Perioperative management and complications
67	L-16	Lung/Examination and diagnosis
68	L-17	Lung/Gene and molecular biology
69	L-18	Lung/Regenerative medicine
70	L-19	Lung/Others

• E. Esophagus

71	E-1	Esophagus/Esophageal malignancies
72	E-2	Esophagus/Esophageal benign diseases
73	E-3	Esophagus/Barrett's esophagus and adenocarcinoma
74	E-4	Esophagus/Esophagectomy and lymphadenectomy
75	E-5	Esophagus/Esophageal reconstruction
76	E-6	Esophagus/Minimally invasive and robotic-assisted surgery
77	E-7	Esophagus/Treatment for recurrent esophageal cancer
78	E-8	Esophagus/Aortoesophageal fistula
79	E-9	Esophagus/Genetics and molecular biology
80	E-10	Esophagus/Pathology and experimental research
81	E-11	Esophagus/Perioperative management and complications
82	E-12	Esophagus/Multidisciplinary treatment
83	E-13	Esophagus/Palliative treatment
84	E-14	Esophagus/Esophageal cancer in elderly
85	E-15	Esophagus/Others

7- Presentation format

Information about presentation format and methodology requirements will be released in due course. These requirements are subject to change. Applicants are advised to check the website for the latest information.

Abstract Submission

【ciphertext-based】（recommended）

【plaintext-based】

Inquiries

Secretariat of the 76th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery c/o Congrès Inc.

E-mail: jats2023-prog@congre.co.jp